Jeff Sacher
Equibles does not estimate personal net worth.
Get an email with a short summary when Foghorn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get FHTX alertsAbout Jeff Sacher
Jeff Sacher is recorded as CFO at Foghorn Therapeutics Inc. (FHTX) since December 3, 2025. Foghorn Therapeutics Inc. reported in an 8-K filed December 4, 2025 that Jeff Sacher was appointed Treasurer, effective December 3, 2025. Foghorn Therapeutics Inc. reported in an 8-K filed December 4, 2025 that Jeff Sacher was appointed interim Chief Financial Officer, effective December 3, 2025. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Adrian Gottschalk (CEO and Board Member), Kristian F. Humer (CFO and Chief Accounting Officer), Ryan D. Maynard (CFO) and 7 others.
“On December 3, 2025, the Board of Directors of Foghorn Therapeutics Inc. (the "Company") appointed Jeff Sacher as Treasurer and interim Chief Financial Officer ("CFO"), effective immediately.”
“On December 3, 2025, the Board of Directors of Foghorn Therapeutics Inc. (the "Company") appointed Jeff Sacher as Treasurer and interim Chief Financial Officer ("CFO"), effective immediately.”
Affiliation history
-
Current
2025-12-03–present
-
Foghorn Therapeutics Inc. (FHTX)
SEC 8-K
Current2025-12-03–present
Company network
Leadership on record at Foghorn Therapeutics Inc.
- Adrian Gottschalk CEO, Board Member
- Kristian F. Humer CFO, Chief Accounting Officer
- Ryan D. Maynard CFO
- Ryan Maynard CFO
- Stephen J. DiPalma CFO
- Steven Bellon CTO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member
- Stuart Duty Board Member